The Reproductive Endocrine Associates Group Practice was established to provide the highest quality reproductive medical care for both men and women, while providing our patients the benefits of the most recent translation of our scientific and technological advances resulting from the ongoing basic and clinical investigations within our Unit. Examples of such novel therapies, derived from our research program and now available in this practice, include pulsatile GnRH for induction of puberty and ovulation and the use of potent GnRH agonists for the treatment of precocious puberty, both of which have now been FDA approved on the basis of studies performed in our Unit.